Concepedia

Second-line Immunotherapy

Second-Line Immunotherapy is a therapeutic strategy in immuno-oncology that refers to the administration of immunotherapeutic agents as the subsequent regimen following the failure or progression of disease after initial treatment with a first-line therapy.

242

Publications

13.1K

Citations

2.5K

Authors

1.1K

Institutions

Publications per year

2017–2026

166

Parents

Publications

242

Randomized Phase III Study of Panitumumab With Fluorouracil, Leucovorin, and Irinotecan (FOLFIRI) Compared With FOLFIRI Alone As Second-Line Treatment in Patients With Metastatic Colorectal Cancer

Marc Peeters, Timothy Price, Andrés Cervantes et al. · Journal of Clinical Oncology · 2010 · 1K citations

, , +15

Ramucirumab versus placebo in combination with second-line FOLFIRI in patients with metastatic colorectal carcinoma that progressed during or after first-line therapy with bevacizumab, oxaliplatin, and a fluoropyrimidine (RAISE): a randomised, double-blind, multicentre, phase 3 study

Josep Tabernero, Takayuki Yoshino, Allen Lee Cohn et al. · The Lancet Oncology · 2015 · 955 citations

, , +12

Lapatinib Plus Paclitaxel Versus Paclitaxel Alone in the Second-Line Treatment of <i>HER2</i>-Amplified Advanced Gastric Cancer in Asian Populations: TyTAN—A Randomized, Phase III Study

Taroh Satoh, Rui‐Hua Xu, Hyun Cheol Chung et al. · Journal of Clinical Oncology · 2014 · 624 citations · Full text

, , +15

Camrelizumab versus investigator's choice of chemotherapy as second-line therapy for advanced or metastatic oesophageal squamous cell carcinoma (ESCORT): a multicentre, randomised, open-label, phase 3 study

Jing Huang, Jianming Xu, Yun Chen et al. · The Lancet Oncology · 2020 · 584 citations

, , +14

Survival with Axicabtagene Ciloleucel in Large B-Cell Lymphoma

Jason R. Westin, Olalekan O. Oluwole, Marie José Kersten et al. · New England Journal of Medicine · 2023 · 410 citations · Full text

, , +17

1–5 of 242

Authors

2.5K

  1. MP
    Marc Peeters

    Antwerp University Hospital, Belgium

    9 publications · 1.4K citations

    9

    h-index

  2. AC
    Andrés Cervantes

    Universitat de València, Spain

    8 publications · 1.4K citations

    8

    h-index

  3. EV
    Eric Van Cutsem

    KU Leuven, Belgium

    7 publications · 2.3K citations

    7

    h-index

  4. TP
    Timothy Price

    Queen Elizabeth Hospital, Australia

    7 publications · 1.4K citations

    7

    h-index

  5. YH
    Yevhen Hotko

    Uzhhorod National University, Ukraine

    6 publications · 1.3K citations

    6

    h-index

1–5 of 2.5K

Institutions

1.1K

  1. Istituti di Ricovero e Cura a Carattere Scientifico

    Rome, Italy

    12 h-index

    49 publications

    3.9K citations

  2. Institut Gustave Roussy

    Villejuif, France

    11 h-index

    32 publications

    1.5K citations

  3. Eli Lilly (United States)

    Indianapolis, United States

    10 h-index

    30 publications

    3.8K citations

  4. National Cancer Center Hospital East

    Kashiwa, Japan

    10 h-index

    25 publications

    902 citations

  5. Sorbonne Université

    Paris, France

    9 h-index

    23 publications

    1.4K citations

  6. Inserm

    Paris, France

    9 h-index

    27 publications

    1.7K citations

  7. Kindai University

    Osaka, Japan

    9 h-index

    9 publications

    358 citations

  8. Shandong First Medical University

    Jinan, China

    8 h-index

    20 publications

    948 citations

1–8 of 1.1K

Venues

  1. Journal of Clinical Oncology

    28 publications · 2.5K citations

    17

    h-index

  2. Frontiers in Oncology

    8 publications · 181 citations

    8

    h-index

  3. Annals of Oncology

    8 publications · 436 citations

    8

    h-index

  4. Journal for ImmunoTherapy of Cancer

    JITC · 6 publications · 326 citations

    6

    h-index

  5. Lung Cancer

    6 publications · 245 citations

    6

    h-index

1–5